MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, specializing in the discovery and development of innovative precision peptide therapies aimed at addressing endocrine and metabolic disorders. Leveraging its proprietary technology platform, MBX is committed to advancing novel therapeutic candidates through rigorous clinical trials. With a focus on unmet medical needs in its targeted therapeutic areas, the company is poised for significant growth and impact in the biopharmaceutical landscape.